5 Indian pharma companies would jointly conduct a clinical trial of COVID drug
They would carry out a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in India
Full Article
5 Indian pharma companies would jointly conduct a clinical trial of COVID drug
Zee News
0 shares
3 views
You might like
Related news coverage
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
Proactive Investors
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal..
-
In a first, 5 Indian pharma majors ally for Covid drug trials
IndiaTimes
-
PureTech Health provides the blue-print for value creation in the life sciences sector
Proactive Investors
-
BetterLife Pharma has a promising pipeline of psychedelic products, a coronavirus nebulizer and AP-001 cream
Proactive Investors
-
NA Proactive news snapshot: Power REIT, Byrna Technologies, CytoDyn, Progressive Planet Solutions, AIM ImmunoTech UPDATE …
Proactive Investors
Advertisement
More coverage
US stocks close higher, recouping last week's losses
Proactive Investors
4.10pm: US stocks finish in the green in strong turnaround from last week The Dow Jones jumped 1.79% to close at 33,876.97 for its..
-
US benchmarks flying higher at lunch as traders brush off inflation fears
Proactive Investors
-
NA Proactive news snapshot: CytoDyn, Progressive Planet Solutions, AIM ImmunoTech, Arizona Silver Exploration UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Falcon Gold, New Oroperu, The Good Shroom, GreenBank Capital, Ridgeline Minerals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: The Good Shroom, GreenBank Capital, Ridgeline Minerals, Braxia Scientific UPDATE …
Proactive Investors